| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3174 | ly-2121260 | Novel glucokinase activator (GKA) |
|
| DCC3175 | ly-2140023 | Novel mGlu2/3 receptor agonist; Prodrug of LY-404039 |
|
| DCC3176 | Ly-231617 | Potent antioxidant, being cytoprotective in models of focal and global cerebral ischemia |
|
| DCC3177 | Ly2389575 | Selective negative allosteric modulator of mGlu3 |
|
| DCC3178 | Ly-278584 | Potent 5-HT3 serotonin receptor antagonist |
|
| DCC3179 | ly2886721 Hydrochloride | Orally active cell-permeable inhibitor of human |
|
| DCC3180 | Ly2934747 | Novel, potent, and systemically bioavailable mGlu2/3 receptor agonist, exhibiting both antipsychotic and analgesic properties in vivo |
|
| DCC3181 | ly-294002 Hydrochloride | Selective cell permeable phosphatidylinositol 3-kinase (PI3K) inhibitor |
|
| DCC3182 | Ly2979165 Ammonium Salt | Novel highly potent and selective agonist of metabotropic glutamate (mGlu) receptors 2 and 3 |
|
| DCC3183 | Ly-333531 Mesylate | Potent and selective inhibitor of PKCβI and PKCβII |
|
| DCC3184 | Ly339434 | Potent GluR5 kainate receptor agonist |
|
| DCC3185 | Ly382884 | Selective GluR5 kainate receptor antagonist |
|
| DCC3186 | Ly392098 | AMPA receptor potentiator |
|
| DCC3187 | Ly-395153 | Allosteric modulator of AMPA receptors |
|
| DCC3188 | Ly444711 | Orally active ghrelin agonist, bindjng with high affinity to and being a potent activator of the growth hormone secretagogue receptor 1a (GHS-R1a) receptor |
|
| DCC3189 | Ly451646 | AMPA receptor potentiator |
|
| DCC3190 | Ly456236 Hydrochloride | Selective mGlu1 receptor antagonist |
|
| DCC3191 | Ly-465608 | Novel potent and selective dual PPARalpha/gamma agonist |
|
| DCC3192 | Ly-466195 | Novel competitive GLUK5 receptor antagonist |
|
| DCC3193 | Ly544344 | Prodrug of LY354740, highly selective and potent agonist of group II mGlu receptors (mGluR2) |
|
| DCC3194 | Ly-580276 | Novel inhibitor of the type I transforming growth factor beta receptor (TβRI) |
|
| DCC3195 | Lyc-31138 | Novel F1F0-ATPase modulator, significantly decreasing M2 glutamate and increasing M4 glutamate |
|
| DCC3196 | Ly-hn2am | Nove fluorescent probe for highly sensitive monitoring drug induced lysosomal pH value changes, exhibiting good biological compatibility, low cytotoxicity and high resistance to photobleaching |
|
| DCC3197 | Lyngbyastatin 7 | Natural Potent Marine-Derived Elastase Inhibitor |
|
| DCC3198 | Lysine Orotate | Inhibitor of viral replication, especially useful in the treatment of the Herpes family of viruses which includes Herpes Simplex 1 and 2 , EBV , CMV and Varicella. |
|
| DCC3199 | Lyso-7 | Inhibitor of cyclooxygenase (COX); Pan partial agonist of PPARγ, PPARα and PPARβ/δ |
|
| DCC3200 | Lzz-02 | Novel inhibitor of the transcriptional activity of β-catenin, degrading the expression of β-catenin by stabilizing axin 2 and diminishing downstream proteins levels, including c-Myc and cyclin D1, effectively shrinking tumor xenograft derived from colonic |
|
| DCC3201 | M-084 Hydrochloride | TRPC4/5 channel blocker, exhibiting antidepressant and anxiolytic effects |
|
| DCC3202 | M1-pam-a | Novel selective muscarinic M1 receptor positive allosteric modulator, significantly improved scopolamine-induced cognitive deficits without prominent signs of diarrhea at up to 1000 mg/kg in mice |
|
| DCC3203 | M1-pam-b | Novel selective muscarinic M1 receptor positive allosteric modulator, showed both significant improvement of scopolamine-induced cognitive deficits and severe diarrhea |
|
